Market Cap: $5.22M
PI
Pulmatrix, Inc.
PULM
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $5.22M
Pulmatrix and Eos SENOLYTIX Forge a New Path in Anti-Aging Treatments On March 26, 2026, Pulmatrix, Inc. announces a definitive merger with Eos SENOLYTIX, marking a significant development in the biot…
Pulmatrix Explores New Merger Avenues Following Cullgen Termination Pulmatrix, Inc. finds itself at a crossroads as it grapples with the recent termination of its merger agreement with Cullgen Inc. Th…
Pulmatrix Faces Merger Setback but Remains Optimistic About Future Opportunities Pulmatrix, Inc., a biopharmaceutical company known for developing innovative inhaled therapeutics, experiences a signif…
Pulmatrix Faces Merger Setback, Shifts Focus to New Opportunities In a significant development for Pulmatrix, Inc., the company learns of the termination of its Merger Agreement with Cullgen Inc. as o…
Pulmatrix Advances Merger Plans Amid Regulatory Delays Pulmatrix, Inc., a biopharmaceutical company specializing in inhaled therapeutic products for migraine and respiratory diseases, is actively navi…
Pulmatrix Pursues Merger Approval Amid Ongoing Strategic Developments Pulmatrix, Inc. is currently advancing its merger efforts with Cullgen Inc., focusing on obtaining the necessary approval from the…